GSK is a global biopharma focused on vaccines, HIV and respiratory and specialty medicines. It trades on London Stock Exchange under the ticker GSK, in the Pharmaceuticals sector.
Key Facts
| Item | Details |
|---|---|
| Ticker | GSK |
| Exchange | London Stock Exchange (GSK) |
| Sector | Pharmaceuticals |
| Headquarters | London, UK |
Bull Case & Risks
Bull Case
- Strong vaccines and HIV franchises
- Improving pipeline momentum
- A reasonable valuation
Risks
- Litigation (Zantac) overhang
- Patent and pipeline risk
Outlook
GSK is a vaccines-and-specialty pharma rebuilding its pipeline credibility after splitting off its consumer arm.
Educational information only, not investment advice. Stocks carry risk including possible loss of principal; past performance does not guarantee future results.